Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a line '2018 ( U.S. NIH Grant/Contract )' to the study identifiers, indicating NIH grant attribution for this trial.
    Difference
    0.1%
    Check dated 2026-08-24T17:34:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.4 to v3.6.5, representing a refreshed edition of the page. No substantive study information or navigation changes are indicated by this update.
    Difference
    0.1%
    Check dated 2026-08-10T11:39:07.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This represents a minor administrative update to the page's version rather than any change to the study information.
    Difference
    0.1%
    Check dated 2026-07-27T06:20:26.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added the page revision indicator Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-07-05T14:24:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the study details page.
    Difference
    0.1%
    Check dated 2026-06-28T08:20:42.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants', indicating enrollment has ceased. New help sections for reading the study record and joining the study were added, while minor formatting and revision notes were updated.
    Difference
    0.4%
    Check dated 2026-06-14T04:43:29.000Z thumbnail image

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.